Previous studies have implicated the rasH, oncogene in the initiation of skin carcinogenesis and the fos oncogene in malignant progression of premalignant skin cell lines. To determine if these two oncogenes are sufficient to convert normal keratinocytes to cancer cells, freshly isolated mouse keratinocytes were coinfected with replication-defective
convert normal keratinocytes to cancer cells, freshly isolated mouse keratinocytes were coinfected with replication-defective (qk-2) v-rasH' and v-fos viruses in culture. When tested in nude mice within several days of infection, v-fos/v-rasH-coinfected keratinocytes produced squamous cell carcinomas. Introduction of v-fos alone resulted in normal or hyperplastic skin, whereas v-rasH1 alone produced squamous papillomas. These results indicate that two oncogenes are sufficient to produce the malignant phenotype in epidermal cells. Furthermore, they clearly link thefos oncogene with malignant conversion. Since fos acts as a transcriptional regulator of other genes, malignant conversion may be an indirect consequence of the overexpression of the fos-encoded protein leading to a change in the expression offos-controlled cellular genes.
Experimental tumor induction is a multistep process that often proceeds through the formation of a benign precursor lesion prior to overt malignancy. In mouse skin carcinogenesis, the evolution of squamous carcinomas requires several genetic changes in the target cells since benign lesions (papillomas) formed in response to a single carcinogen exposure progress to malignancy at an accelerated rate if the tumor-bearing host is exposed to additional mutagenic carcinogens (1) . Isolation of a c-rasHa oncogene from 7,12-dimethylbenz [a] anthracene and certain other polycyclic hydrocarbon-initiated skin papillomas and the formation of papillomas following the introduction of v-rasHa into normal skin cells (2) (3) (4) (5) indicate that activation of c-rasHa is one type of early genetic change in mouse skin carcinogenesis associated with benign tumor formation. Further changes in c-rasHa genes, such as overexpression, amplification, and homozygosity, have been associated with malignant progression (6, 7) . Changes in the fos gene have recently been implicated in skin carcinogenesis since transfection of oncogenic fos constructs converted established papilloma cell lines in culture to the carcinoma phenotype, whereas myc and EJA oncogenes did not (8) . Since the papilloma cell lines contained an activated c-ras Ha gene (9) , the results implied that rasHa and fos genes could cooperate in malignant conversion of keratinocyte neoplasms. However, the prolonged cell culture maintenance of papilloma cell lines (9) may have produced other genetic changes in addition to the activating rasHa gene mutation defined at codon 61.
We now demonstrate that coinfection of primary murine keratinocytes with helper-free (qi-2) Finkel-Biskis-Reilly (FBR) or Finkel-Biskis-Jinkins (FBJ) v-fos and v-rasHa retroviruses resulted in carcinomas when recipient cells were tested in nude mice. Introduction of only v-fos produced normal or hyperplastic skin, whereas v-rasHa produced papillomas. Thus, two oncogene events are sufficient to produce the malignant phenotype in epidermal cells. (13) . Morphological transformants were cloned and conditioned medium from 4i-2 cell lines was titered using the NIH 3T3 focus formation assay. A replication-defective variant of Ha MSV that comprised a v-rasHa gene possessing mutations at codons 12 and 59 was generated as described (5) . In addition, as a negative control, a i1-2 neo virus was generated by transfecting cloned pZIPneo DNA (14) into i1-2 cells and subsequent G418 selection.
MATERIALS AND METHODS
Primary newborn BALB/c keratinocytes were prepared as described (15) and plated at 1 x 107 cells per 175-cm2 flask. Cultures were maintained in fibroblast-conditioned Eagle's minimal essential medium containing 0.05 mM Ca2+, a calcium concentration that selects for basal cells (15) . The medium had been previously conditioned by primary dermal fibroblasts to enhance cell growth (16 Infected cells (5 x 106 per mouse) were also injected subcutaneously into the interscapular area of nude mice. Tumorbearing animals were sacrificed at 4 weeks. Control and non-tumor-bearing animals (including graft failures) were scored at 10-12 weeks. Graft sites and subcutaneous nodules were processed for routine histological staining by hematoxylin/eosin as well as for special analysis as described below.
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Tumor diagnoses were determined grossly by the extent of local invasion and ulceration and confirmed histologically by the standard criteria of cellular atypia, tissue organization, invasion, and metastasis. Northern Analysis, Immunofluorescence, and Histochemistry. Four weeks after in vivo application of cells, tumorbearing mice were sacrificed, and the tumors were excised and frozen in liquid nitrogen. Total RNA was prepared according to the method of Chirgwin et al. (17) , separated by agarose gel electrophoresis, and transferred to nitrocellulose. Filters were probed with (i) a v-ras-specific probe isolated from plasmid BS9 (18); (it) a v-fos-specific probe isolated as a 1.8-kilobase (kb) Bgl II fragment from plasmid pFBJR2 (11); or (iii) a keratin 14 (K14)-specific probe to account for loading or transfer discrepancies (19) . Filters were washed to a final stringency of 15 mM NaCl/1.5 mM sodium citrate/0.1% sodium dodecyl sulfate (SDS) at 680C prior to autoradiography using Kodak X-Omat film with intensifying screen at -700C.
At the time of sacrifice, a portion of the excised tumor was placed in embedding medium (OCT, Miles Scientific), frozen in dry ice, and later sectioned onto glass slides. For doublestaining immunofluorescence, frozen sections were incubated with affinity-purified monospecific rabbit antibody to mouse keratin 1 (K1) (AF109, diluted 1:500) and guinea pig antibody to mouse K14 (diluted 1:2000) for 20 hr as described (20) . For K14 visualization, biotin anti-guinea pig IgG was used in conjunction with streptavidin Texas red. For K1 visualization, a secondary fluorescein isothiocyanate-labeled anti-rabbit IgG was employed. y-Glutamyl transpeptidase staining was performed on frozen sections as described (8) .
RESULTS
Grafts of mock-infected or fi-2 neo-infected keratinocytes produced a normal epidermis, and no lesions developed at subcutaneous injection sites (Table 1 ; Fig. 1 (5) . Later tumors (28 days) were very invasive and some were metastatic (see Fig. 2D ). Histologically, the malignant tumors ranged from poorly differentiated to a moderately well-differentiated phenotype, but all were typical epidermal carcinomas.
Grafts of primary keratinocytes infected with either type of q/-2 v-fos virus produced normal or, in certain cases, a hyperplastic donor skin (Fig. 1B) (Table 1) after 10-12 weeks.
Northern analysis, performed on RNA extracted from grafted and subcutaneous tumors, confirmed the uptake and expression of exogenous viral genes (Fig. 3) . All of the neoplasms examined (28/28) expressed the 1-to 5-kb bands characteristic of the v-rasHa construct expressed in epidermal tumors (4) . A c-rasHa transcript (1.4 kb) was not detected in normal mouse skin with this probe. The carcinomas from combined exposures (15/15) in addition showed the 3.5-kb v-fos transcript, whereas benign v-rasHa tumors and normal skin did not have a transcript that hybridized to the v-fos probe. The absence of detectable cellular rasHa and fos protooncogenes in normal skin could in part be related to the lower amount of RNA loaded in lane a as detected by the K14 probe in the lower panel. However, these transcripts were noted to be in very low abundance in normal skin (22) .
The histological diagnosis of many of the keratinocytederived tumors was confirmed by characteristic markers that can distinguish malignant tumors from benign tumors and normal skin. K1 is a differentiation-specific keratin expressed in normal skin and papillomas but not in carcinomas, whereas K14 is a basal cell keratin expressed in normal skin and both tumor types (20, 23) . Specific antisera in two species allow for the analysis of these markers in tissue sections (20) (4/4) exhibited normal patterns of expression for these two keratins. Histochemically detectable y-glutamyl transpeptidase activity is commonly observed in 7,12-dimethylbenz[a]-anthracene-initiated skin carcinomas and absent from interfollicular epidermis and papillomas (24) . However, qi-2 vfos/v-rasHa carcinomas (16/16) were devoid of detectable y-glutamyl transpeptidase activity, as were v-ras Ha-induced papillomas (9/9). As in our previous study (8) , the y-glutamyl Proc. Natl. Acad. Sci. USA 87 (1990) tion of transforming rasHa p21 protein into NIH 3T3 cells, which produced a transient increase in c-fos expression (25) . Similarly, c-fos expression and expression of a c-fos promoter-CAT construct were stimulated >10-fold by introduction of a ras protooncogene or ras oncogene into 3T3 cells (26) . However, we did not see a c-fos signal when RNA from v-ras-induced papillomas was probed with v-fos, suggesting that the endogenous transcript is not elevated. This is consistent with our previous analysis of chemically induced mouse skin tumors (22) and tumor cell lines (8) . Thefos gene is known to be a regulator of transcription, forming a complex with p39, the c-jun/APi protooncogene product, and this modulates gene expression by binding to the AP1 regulatory site (27, 28 phenotype. Experiments are necessary to further test this hypothesis.
The failure of /-2 v-fos or either wild-typefos MSV virus to alter the phenotype of newborn keratinocytes contrasts with the transforming nature of these genes in some other systems (10, 11) . This result was consistent in eight experiments comprising 55 animals and six separate high-titer virus preparations. Previously, c-fos expression was demonstrated to increase transiently under conditions of epidermal hyperproliferation (30) , but permanent up-regulation offos has not been reported in skin. It has been shown previously that the introduction of v-rasHa alters the differentiation program of normal keratinocytes (31) . Thus, the action offos on normal keratinocytes may be abrogated by an intact intrinsic differentiation program but becomes effective in neoplastic cells where the differentiation program is altered.
